GW Chosen as Site for COVID-19 Phase 3 Vaccine Trial

The George Washington University is one of approximately 90 sites chosen for the first Phase 3 clinical trial of a COVID-19 vaccine candidate in the US. Watch: https://wjla.com/news/local/500-covid-19-vaccine-volunteers-needed-for-dc-trial